September 10-13, 2019

Boston, MA, USA
Twitter logo for website footers 2

The CAR-TCR Summit Boston is returning for the 5th year as the premier, industry-focused summit dedicated to the clinical and commercial development of durable, safe and cost-effect, CAR-T and TCR based cell therapies for patients globally. Providing you with a comprehensive end-to-end guide to CAR-TCR drug development, the CAR-TCR Summit remains at the forefront of the industry bringing you never-seen-before data from the movers and shakers in CAR-T and TCR therapy development. Join 1000 expert CAR-TCR drug developers to discuss these key topics:

  • Novel CAR and TCR constructs to enhance potency and targeting
  • Is autologous therapy becoming a thing of the past?
  • How to set up an infrastructure to run CAR-T trials effectively?
  • Managing heterogeneity and process variation in autologous manufacture
  • Optimize supply chain coordination to secure chain of custody
  • Pricing Models to make CAR and TCR therapies affordable

Network with CAR-TCR industry pioneers and leave with the tangible takeaways you need to develop a targeted, efficacious and accessible CAR or TCR product to cure patients in need around the world. Register your interest at info@hansonwade.com

CAR-TCR Summit Europe

February 25-27 2019 | London

CAR-TCR Summit Asia

June 18-20, 2019 | Shanghai

Please register your interest below to receive updates about next year’s agenda for the CAR-TCR Summit.

"I can't speak highly enough about this conference. This conference allowed me to keep informed of the latest research and development on T cell therapies. I was also able to network with some of the leaders in T cell immunotherapies from both academia and the industry."

-Arnab Ghosh, Hematology & Medical Oncology Fellow, MSKCC, CAR-TCR Summit 2017 attendee